WestMARC Prosthetic Department, Queen Elizabeth University Hospital, Glasgow, UK.
Prosthet Orthot Int. 2023 Apr 1;47(2):124-129. doi: 10.1097/PXR.0000000000000166. Epub 2022 Jul 8.
Multiarticulating hands (MAHs) have been commercially available for over 15 years. Despite this, their cost remains significantly higher than traditional electric hands, and they are not routinely available in many countries. The Scottish Specialist Prosthetic Service within the National Health Service has been prescribing MAHs since 2014. However, the benefits of MAHs provided in clinical settings are not well known.
This study aimed to compare patient-reported and functional measures in unilateral transradial prosthetic users transitioning from a body-powered or traditional myoelectric prosthesis to a MAH.
This was a retrospective cohort analysis of individuals with a unilateral transradial amputation provided with a MAH.
Of 38 users provided with MAHs, 20 had complete data sets of patient-reported and functional measures before and 6 months after provision. These included Disabilities of the Arm, Shoulder, and Hand; Southampton Hand Assessment Procedure Index of Function; health-related quality of life (EQ-5D-5L Health Index); Trinity Amputation and Prosthesis Experience Scales satisfaction; and Box and Block Test.
The mean age was 44 years (SD 16) (n = 20), and 75% were male. There were an 8-unit mean reduction in the Disabilities of the Arm, Shoulder, and Hand ( P = .01) and a 9.5-unit improvement in the Southampton Hand Assessment Procedure IOF ( P = .007) at 6 months after provision. Health-related quality of life did not change ( P = .581). Users reported a four-point improvement in their Trinity Amputation and Prosthesis Experience Scales ( P = .004) and transferred 3.3 blocks more completing the Box and Block Test ( P = .001).
The evidence clearly supports continued provision of MAHs to this group of moderate users: the more function the user achieves, the less of a disability they perceive to have.
多关节手(MAHs)已经商业化应用超过 15 年。尽管如此,它们的成本仍然明显高于传统电动手,而且在许多国家都没有常规供应。苏格兰国家卫生服务局的专科假肢服务自 2014 年以来一直在开 MAHs 的处方。然而,在临床环境中提供 MAHs 的好处并不为人所知。
本研究旨在比较单侧桡骨截肢患者从身体驱动或传统肌电假体过渡到 MAH 后,患者报告的和功能测量结果。
这是对使用 MAH 的单侧桡骨截肢患者的回顾性队列分析。
在提供 MAHs 的 38 名患者中,有 20 名患者有完整的患者报告和功能测量数据集,包括手臂、肩部和手的残疾程度(DASH);南安普顿手部评估程序功能指数(Southampton Hand Assessment Procedure Index of Function);健康相关生活质量(EQ-5D-5L 健康指数);三位一体截肢和假体体验量表满意度;和 Box 和 Block 测试。
患者的平均年龄为 44 岁(标准差 16)(n=20),75%为男性。在提供后的 6 个月,DASH 平均减少了 8 个单位(P=.01),南安普顿手部评估程序 IOF 改善了 9.5 个单位(P=.007)。健康相关生活质量没有变化(P=.581)。患者报告三位一体截肢和假体体验量表提高了 4 分(P=.004),在 Box 和 Block 测试中多转移了 3.3 个方块(P=.001)。
有证据清楚地支持继续向这组中度使用者提供 MAHs:使用者的功能越多,他们感知到的残疾就越少。